Harvard Apparatus Regenerative Technology sells 2,703,727 shares in USD 2.84 million private placement at USD 1.05 each
HRGN•Private placement priced and closed
Harvard Apparatus Regenerative Technology priced a private placement of 2,703,727 common shares at USD 1.05 each.
Gross proceeds totaled USD 2,838,911; the financing closed Sept. 11, 2026.
CEO participated through note conversion
CEO Jerry (Junli) He took 683,725 shares via conversion of USD 717,911 of bridge promissory notes.
Shares were issued without registration under Section 4(a)(2) and Rule 506.
